Literature DB >> 28439970

Dasatinib-associated follicular lymphoid hyperplasia: First pediatric case report and literature review.

Emilie Bouquet1, Anne Jourdain2, Marie-Christine Machet3,4, Frédérique Beau-Salinas1, Annie-Pierre Jonville-Béra1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28439970     DOI： 10.1002/pbc.26597

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  2 in total

1.  A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer.

Authors:  Chul Kim; Stephen V Liu; Jennifer Crawford; Tisdrey Torres; Vincent Chen; Jillian Thompson; Ming Tan; Giuseppe Esposito; Deepa S Subramaniam; Giuseppe Giaccone
Journal:  Front Oncol       Date:  2021-09-08       Impact factor: 6.244

2.  Dasatinib associated lymphadenopathy in a chronic myeloid leukemia patient: A case report.

Authors:  Dimitrios Pilalas; Triantafyllia Koletsa; Georgios Arsos; Grigorios Panselinas; Paraskevi Exadaktylou; George Polychronopoulos; Christos Savopoulos; Georgia D Kaiafa
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.